Visus Therapeutics appoints 6 executive leaders

Ophthalmic pharmaceutical company Visus Therapeutics introduced six new executives it has appointed to lead the company.

Advertisement

The six appointments are Tim Grinstead as COO; James Burke as vice president of research; Patrick Hughes, PhD, as vice president of pharmaceutical development; Lisa Simpson as vice president of clinical operations and compliance; Guru Sharma, OD, as director of ophthalmology and clinical development; and Alex Oh as vice president of intellectual property.

Visus Therapeutics is a clinical-stage company with offices in Seattle and Orange County, Calif.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in Ophthalmology

  • East Lansing-based Michigan Surgical Center has disclosed a data breach that may have exposed personal information, according to a July…

  • Cincinnati-based MidWest Eye Center welcomed Alec Bradley, MD, an ophthalmologist who specializes in premium cataract surgery, refractive surgery, microinvasive glaucoma…

Advertisement

Comments are closed.